These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 15775409)

  • 21. Prolonged-efficacy of bisphosphonate in postmenopausal women with osteoporosis and chronic liver disease.
    Arase Y; Suzuki F; Suzuki Y; Akuta N; Kobayashi M; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Ikeda K; Kumada H
    J Med Virol; 2008 Jul; 80(7):1302-7. PubMed ID: 18461628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term etidronate treatment prevents glucocorticoid-induced bone debility of the mandible in growing rats.
    Fujita Y; Konoo T; Maki K
    Orthod Craniofac Res; 2008 Nov; 11(4):187-95. PubMed ID: 18950314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of vibration therapy on bone mineral density in postmenopausal women with osteoporosis.
    Ruan XY; Jin FY; Liu YL; Peng ZL; Sun YG
    Chin Med J (Engl); 2008 Jul; 121(13):1155-8. PubMed ID: 18710630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats.
    Noonan W; Koch K; Nakane M; Ma J; Dixon D; Bolin A; Reinhart G
    Nephrol Dial Transplant; 2008 Dec; 23(12):3824-30. PubMed ID: 18644798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
    Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
    Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different risk factors for vascular calcification in end-stage renal disease between diabetics and nondiabetics: the respective importance of glycemic and phosphate control.
    Ishimura E; Okuno S; Taniwaki H; Kizu A; Tsuchida T; Shioi A; Shoji T; Tabata T; Inaba M; Nishizawa Y
    Kidney Blood Press Res; 2008; 31(1):10-5. PubMed ID: 18097148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone pain in dialysis patients is not associated with bone mineral density but with serum concentration of small uremic toxins.
    Grzegorzewska AE; Młot-Michalska M
    Adv Med Sci; 2007; 52():228-31. PubMed ID: 18217423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Atherosclerosis and bisphosphonate].
    Shioi A
    Clin Calcium; 2003 Feb; 13(2):169-72. PubMed ID: 15775079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of arterial calcification in patients with chronic limb threatening ischemia with etidronate: protocol of an investigator-initiated multicenter, double blind, placebo-controlled, randomized clinical trial.
    Hoogervorst R; van Overhagen H; de Jong PA; Spiering W; de Borst GJ; Veger HTC; Mairuhu ATA; Mali WPTM
    CVIR Endovasc; 2022 Jun; 5(1):26. PubMed ID: 35666322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skeletal abnormalities secondary to antenatal etidronate treatment for suspected generalised arterial calcification of infancy.
    Agarwal N; Agarwal U; Alfirevic Z; Lim J; Kaleem M; Landes C; Mughal MZ; Ramakrishnan R
    Bone Rep; 2020 Jun; 12():100280. PubMed ID: 32490054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antiatherogenic actions of etidronate on atherosclerosis].
    Koshiyama H
    Clin Calcium; 2002 Mar; 12(3):378-82. PubMed ID: 15775318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etidronate, calcium, or both did not reduce fracture rates in patients with asthma receiving glucocorticoid treatment.
    Jamal SA
    ACP J Club; 2005; 142(2):44. PubMed ID: 15739991
    [No Abstract]   [Full Text] [Related]  

  • 34. Retraction notice to "Beneficial Effect of Etidronate Therapy in Chronically Hospitalized, Disabled Patients with Stroke" [Journal of Stroke and Cerebrovascular Diseases, Volume 19, Issue 3, May 2010, Pages 198-203].
    Sato Y; Iwamoto J; Honda Y
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2362. PubMed ID: 31375260
    [No Abstract]   [Full Text] [Related]  

  • 35. Response to 'On vascular calcification prevention with phosphonoformate and bisphosphonates'.
    Lomashvili KA; O'Neill WC
    Kidney Int; 2009 Jun; 75(12):1356. PubMed ID: 30060397
    [No Abstract]   [Full Text] [Related]  

  • 36. Zinc Deficiency Promotes Calcification in Vascular Smooth Muscle Cells Independent of Alkaline Phosphatase Action and Partly Impacted by Pit1 Upregulation.
    Alcantara EH; Kwon JH; Kang MK; Cho YE; Kwun IS
    Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Suppressive effects of bisphosphonates on the vascular calcification in ESRD patients].
    Tamura K; Hashiba H; Kogo H; Aizawa S; Shigematsu T
    Clin Calcium; 2002 Aug; 12(8):1129-35. PubMed ID: 15775409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effects of etidronate on the progression of vascular calcification in hemodialysis patients.
    Hashiba H; Aizawa S; Tamura K; Shigematsu T; Kogo H
    Ther Apher Dial; 2004 Jun; 8(3):241-7. PubMed ID: 15154878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: long-term effects.
    Hashiba H; Aizawa S; Tamura K; Kogo H
    Ther Apher Dial; 2006 Feb; 10(1):59-64. PubMed ID: 16556138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of aortic calcification by etidronate in the renal failure rat model.
    Tamura K; Suzuki Y; Matsushita M; Fujii H; Miyaura C; Aizawa S; Kogo H
    Eur J Pharmacol; 2007 Mar; 558(1-3):159-66. PubMed ID: 17270170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.